Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex-biased adaptive immune regulation in cancer development and therapy.
Schafer JM, Xiao T, Kwon H, Collier K, Chang Y, Abdel-Hafiz H, Bolyard C, Chung D, Yang Y, Sundi D, Ma Q, Theodorescu D, Li X, Li Z. Schafer JM, et al. Among authors: bolyard c. iScience. 2022 Jul 4;25(8):104717. doi: 10.1016/j.isci.2022.104717. eCollection 2022 Aug 19. iScience. 2022. PMID: 35880048 Free PMC article. Review.
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity.
Li A, Chang Y, Song NJ, Wu X, Chung D, Riesenberg BP, Velegraki M, Giuliani GD, Das K, Okimoto T, Kwon H, Chakravarthy KB, Bolyard C, Wang Y, He K, Gatti-Mays M, Das J, Yang Y, Gewirth DT, Ma Q, Carbone D, Li Z. Li A, et al. Among authors: bolyard c. J Immunother Cancer. 2022 Sep;10(9):e005433. doi: 10.1136/jitc-2022-005433. J Immunother Cancer. 2022. PMID: 36096533 Free PMC article.
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.
Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, Evans JP, Bucci D, Gunasena M, Xu M, Liyanage NPM, Bolyard C, Velegraki M, Liu SL, Ma Q, Devenport M, Liu Y, Zheng P, Malvestutto CD, Chung D, Li Z. Song NJ, et al. Among authors: bolyard c. J Hematol Oncol. 2022 Jan 10;15(1):5. doi: 10.1186/s13045-021-01222-y. J Hematol Oncol. 2022. PMID: 35012610 Free PMC article. Clinical Trial.
Transforming growth factor-β1 in regulatory T cell biology.
Moreau JM, Velegraki M, Bolyard C, Rosenblum MD, Li Z. Moreau JM, et al. Among authors: bolyard c. Sci Immunol. 2022 Mar 18;7(69):eabi4613. doi: 10.1126/sciimmunol.abi4613. Epub 2022 Mar 18. Sci Immunol. 2022. PMID: 35302863 Free PMC article. Review.
Sex as a biological variable in response to temozolomide.
Russell L, Bolyard C, Banasavadi-Siddegowda Y, Weiss A, Zhang J, Shakya R, Powell K, Kaur B. Russell L, et al. Among authors: bolyard c. Neuro Oncol. 2017 Jun 1;19(6):873-874. doi: 10.1093/neuonc/nox040. Neuro Oncol. 2017. PMID: 28379437 Free PMC article. No abstract available.
Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation.
Nair M, Khosla M, Otani Y, Yeh M, Park F, Shimizu T, Kang JM, Bolyard C, Yu JG, Kumar Banasavadi-Siddegowda Y, Lopez G, Kaur B, Pollock RE, Lee TJ, Old M, Yoo JY. Nair M, et al. Among authors: bolyard c. Cancers (Basel). 2020 Apr 23;12(4):1040. doi: 10.3390/cancers12041040. Cancers (Basel). 2020. PMID: 32340193 Free PMC article.
31 results